Where to buy Tivozanib

Tivozanib is a drug used to treat adults with advanced renal cell carcinoma (a type of kidney cancer). Tivozanib may be used in previously untreated patients or in those whose disease worsens despite treatment with another drug that works in a different way. It contains the active substance tivozanib, which works by blocking the activity of a protein called VEGF, which stimulates the formation of new blood vessels. By blocking this protein, tivozanib prevents the formation of new blood vessels that tumors need, thereby cutting off their blood supply and reducing cancer growth.

Tivozanib is available in capsule form (890 and 1340 mcg), and the usual dose is one 1340 mcg (1.34 mg) capsule per day for three weeks, with the patient not taking any capsules the following week. Patients should continue to repeat this 4-week course as long as the disease does not worsen or until side effects become unacceptable. If a patient has troublesome side effects, the doctor may decide to switch to a lower-strength 890 mcg capsule or interrupt treatment. Tivozanib is currently only available by prescription, and treatment should be done under the supervision of a doctor experienced in treating cancer.

The original drug Tivozanib has not yet been launched in China, so it has not been included in medical insurance. Domestic patients cannot yet purchase this drug through relevant domestic channels. The European version of tivozanib Original drug, specifications1340mcg*21 pills sold overseas may cost around 30,000 yuan per box (the price may fluctuate due to exchange rates), which is relatively expensive. There is currently no generic version of tivozanib available on the market. For more drug information and specific prices, please consult a medical consultant.